Intel’s central processing units have Wall Street excited right now, but what really matters for the company’s financial turnaround is whether it can secure manufacturing customers. And on Tuesday, ...
Cell and gene therapy manufacturers are partnering with specialist technology companies to address the challenges associated with scaling complex therapies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results